Glaxosmithkline Consumer Profile
Key Indicators
- Authorised Capital ₹ 125.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 119.73 Cr
as on 24-10-2024
- Company Age 10 Year, 15 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 55.72%
(FY 2023)
- Profit 5.43%
(FY 2023)
- Ebitda 3.28%
(FY 2023)
- Net Worth -16.84%
(FY 2023)
- Total Assets 2.12%
(FY 2023)
About Glaxosmithkline Consumer
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 125.00 Cr and a paid-up capital of Rs 119.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Glaxosmithkline Consumer Private Limited India is Meenu Singhal as COMPANY SECRETARY. Rupendra Yadav, Vikas Gupta, and Raj Khemani serve as directors at the Company.
- CIN/LLPIN
U24232PB2014FTC039082
- Company No.
039082
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
04 Dec 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Patiala, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Glaxosmithkline Consumer?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meenu Singhal  | Company Secretary | 16-Jan-2024 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikas Gupta | Nominee Director | 30-Mar-2020 | Current |
| Rupendra Yadav | Nominee Director | 16-Jun-2021 | Current |
| Raj Khemani | Director | 22-Jul-2022 | Current |
Financial Performance and Corporate Structure Insights of Glaxosmithkline Consumer.
Glaxosmithkline Consumer Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.72% increase. The company also saw a slight improvement in profitability, with a 5.43% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glaxosmithkline Consumer?
In 2023, Glaxosmithkline Consumer had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Glaxosmithkline Consumer?
Glaxosmithkline Consumer has a workforce of 536 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glaxosmithkline Consumer, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glaxosmithkline Consumer's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
